No Data
No Data
Truist Financial Reaffirms Their Buy Rating on Argenx Se (ARGX)
Truist Securities Adjusts Price Target on Argenx to $540 From $480, Maintains Buy Rating
05:32 AM EDT, 07/22/2024 (MT Newswires) -- Truist Securities Adjusts Price Target on argenx to $540 From $480, Maintains Buy
Express News | Argenx SE : Truist Securities Raises Target Price to $540 From $480
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Moderna (MRNA) and Argenx Se (ARGX)
A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $500 to $607
On Jul 18, major Wall Street analysts update their ratings for $argenx SE(ARGX.US)$, with price targets ranging from $500 to $607.BofA Securities analyst Tazeen Ahmad maintains with a buy rating,
Argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
July 18, 2024Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it